Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 10/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 9/20 | 0.48 |
| ▸ | KDM1A | O60341 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1136072 | 1.00 | F10 (0.52) | F10PTGS2KDM1A | |
| SCHEMBL15067486 | 1.00 | F10 (0.52) | F10PTGS2KDM1A | |
| Hydrochloric Acid SCHEMBL13278675 | 0.99 | F10 (0.51) | F10PTGS2KDM1A | |
| Hydrochloric Acid SCHEMBL13278677 | 0.99 | F10 (0.51) | F10PTGS2KDM1A | |
| Hydrochloric Acid SCHEMBL13278676 | 0.99 | F10 (0.51) | F10PTGS2KDM1A | |
| SCHEMBL454994 | 0.89 | PTGS2 (0.56) | F10PTGS2 | |
| SCHEMBL13739574 | 0.89 | PTGS2 (0.56) | F10PTGS2 | |
| SCHEMBL15110646 | 0.89 | PTGS2 (0.49) | F10PTGS2KDM1A | |
| SCHEMBL19647436 | 0.89 | PTGS2 (0.49) | F10PTGS2KDM1A | |
| SCHEMBL117112 | 0.89 | PTGS2 (0.56) | F10PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013098833-A2 | PROCESSES AND INTERMEDIATES FOR PREPARING RIVAROXABAN | CADILA HEALTHCARE LIMITED (IN) | 2013-07-04 | — | — | WO | claimed |
| EP-2705028-B1 | PROCESS FOR THE PREPARATION OF A RIVAROXABAN AND INTERMEDIATES FORMED IN SAID PROCESS | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 2019-08-21 | — | — | EP | disclosed |
| US-9221771-B2 | Method for the preparation of substituted oxazolidinones | SANDOZ AG (CH) | 2015-12-29 | — | — | US | disclosed |
| CN-104592143-A | Method for preparing oxazolidinone compound | UNIV SICHUAN | 2015-05-06 | — | — | CN | disclosed |
| US-20140378682-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING RIVAROXABAN | CADILA HEALTHCARE LIMITED (IN) | 2014-12-25 | — | — | US | disclosed |
| US-20140213784-A1 | METHOD FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDINONES | SANDOZ AG (CH) | 2014-07-31 | — | — | US | disclosed |
| WO-2013098833-A2 | PROCESSES AND INTERMEDIATES FOR PREPARING RIVAROXABAN | CADILA HEALTHCARE LIMITED (IN) | 2013-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213784-A1 | METHOD FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDINONES | OXA1L, XDH, AOX1 | F10 1297/4885PTGS2 1605/4885KDM1A 2273/4885 |
| US-20140378682-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING RIVAROXABAN | VKORC1, VKORC1L1, F2 | F10 11/4885PTGS2 1904/4885KDM1A 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.